跳至主要内容
临床试验/NCT07281287
NCT07281287招募中不适用

Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation

University of Alabama at Birmingham1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
1
主要终点
Change in financial hardship

研究概览

简要总结

The purpose of this study is to understand the implementation and impact of a pragmatically-delivered oncology financial navigation program. The main questions it aims to answer are:

  1. How did oncology financial navigation implementation strategies affect implementation outcomes?
  2. What is the impact of financial navigation on patient financial hardship, quality of life, and psychological distress?
  3. How were implementation strategies utilized to overcome barriers to oncology financial navigation?

Researchers will examine secondary, standard-of-care collected, patient-reported data, electronic medical record data, and qualitative interview data to answer these questions.

详细描述

Guided by the RE-AIM Extension for Equitable Sustainability framework, the investigators will use a series of implementation and effectiveness aims to evaluate equitable implementation of oncology financial navigation into routine cancer care delivery. The investigators hypothesize the proposed assessment will identify potential areas to improve implementation of oncology financial navigation, which will result in better financial and clinical outcomes for patients with cancer. The investigators propose a pragmatic, hybrid effectiveness-implementation study to assess outcomes of oncology financial navigation delivered as routine cancer care and collect information on strategies to address implementation barriers. Outcomes will be assessed overall and for inequities by race, residence, and insurance status using the following specific aims:

Aim 1. Track oncology financial navigation implementation strategies and their effect on implementation outcomes

Aim 2. Evaluate oncology financial navigation effectiveness

Aim 3. Assess how implementation strategies were utilized to overcome barriers to oncology financial navigation

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Inclusion criteria: As oncology financial navigation will be implemented as standard of care, implementation outcomes will be evaluated for:
  • •All patients with cancer seen at the University of Alabama at Birmingham (UAB) Medical Oncology clinic
  • •UAB oncology financial navigators

排除标准

  • •Inclusion criteria: This will be a secondary data analysis of patient-reported data routinely collected since 2020, which will include:
  • •Patients with cancer seen at the UAB Medical Oncology clinic
  • •Patients with non-missing patient-reported outcome data
  • •Exclusion criteria: None.
  • •Inclusion criteria:
  • •Patients who have received oncology financial navigation
  • •Providers (oncology financial navigators, social workers, nurse managers, oncologists) involved with the oncology financial navigation program
  • •Health system team members (billing specialists, cancer service line leadership) involved with the oncology financial navigation program
  • •Exclusion criteria: None.

研究组 & 干预措施

Patients receiving standard-of-care-delivered financial navigation

Experimental

干预措施: Financial navigation (Behavioral)

Historical control patients who did not receive financial navigation

No Intervention

结局指标

主要结局

Change in financial hardship

时间窗: 6 months post-initiation of systemic therapy

Change in patient-reported financial distress (COmprehensive Score for financial Toxicity)

Change in financial difficulties

时间窗: 6 months post-initiation of systemic therapy

Change in patient-reported financial difficulties (trouble paying for basic needs, utilities, transportation or lodging for treatment, medications, medical supplies, upfront medical payments, insurance or medical bills, child or eldercare, and employment or disability issues)

Change in quality of life

时间窗: 6 months post-initiation of systemic therapy

Change in patient-reported quality of life (PROMIS v1.1 Global Health)

Change in psychological distress

时间窗: 6 months post-initiation of systemic therapy

Change in patient-reported psychological distress (National Comprehensive Cancer Network Distress Thermometer)

Utilization of implementation strategies

时间窗: Quarterly tracking of strategies with monthly assessment of implementation outcomes, through study completion, an average of 4 years

Track oncology financial navigation implementation strategies using the Expert Recommendations for Implementing Change (ERIC) implementation strategy taxonomy and their effect on implementation outcomes of Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM)

Patient, provider, and health system perspectives of oncology financial navigation implementation barriers addressed via implementation strategies

时间窗: Annually through study completion, an average of 4 years

Using qualitative interviews, we will assess patient, provider, and health system perspectives of oncology financial navigation implementation barriers addressed via implementation strategies

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Courtney Williams

Assistant Professor

University of Alabama at Birmingham

研究点 (1)

Loading locations...

相似试验

进行中(未招募)
不适用
Strong Evidence: Digitally Delivered Exercise in Older AdultsFall PreventionFall Prevention in Healthy Aging
NCT07282951University of California, San Diego60
已完成
不适用
A Study to Assess the Effectiveness of a Marketed Denture Adhesive in Real-World SettingDenture Retention
NCT07273149HALEON375
招募中
2 期
CO43923 Master Protocol: A Study Evaluating the Safety and Efficacy of Multiple Treatments in Patients with Multiple Myeloma CO43923 Substudy 1: A Study to Collect Patient-Level Data in Patients with Multiple Myeloma CO43923 Substudy 2 Cevos + Len Treatment: A Study Evaluating the Safety and Efficacy of Cevostamab in Combination with Lenalidomide in Patients with Cytogenetic High-Risk Features Receiving Maintenance Treatment After First Response from Multiple Myeloma Post-Stem Cell Transplant CO43923 Substudy 4 Cevostamab+ Iberdomide Treatment: A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Cevostamab in Combination with Iberdomide in Patients with Relapsed or Refractory Multiple MyelomaMultiple Myeloma (MM)
2023-504484-16-00F. Hoffmann-La Roche AG32
招募中
不适用
Impact of an e-Bug Educational Intervention on HPV Vaccine Uptake in Middle School StudentsPapillomavirus InfectionPapillomavirus VaccinesVaccination Coveage
NCT07266857Centre Hospitalier Universitaire de Nice11,000
尚未招募
不适用
National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) PatientsImmune Thrombocytopenia (ITP)
NCT07268898Institute of Hematology & Blood Diseases Hospital, China500